Abstergo Industries is proud to announce our latest satellite program, the Akashic Satellite Plexus® 2.0. This program builds on the success of our previous satellite programs, including the original Akashic Satellite Plexus® launched in 2008 and the EYE-ABSTERGO® satellite launched in 2012. Our goal with this new program is to extend the reach and capabilities […]
Author: Wolf Rasmussen
Abstergo Industries is dedicated to advancing the science of aging and developing treatments to slow the aging process. Aging is a complex process that involves a variety of biological pathways and mechanisms, including genetic, environmental, and lifestyle factors. Our research focuses on understanding these pathways and developing interventions that can target them to extend healthy […]
Abstergo Industries is excited to announce the development of a new pharmaceutical product that has the potential to revolutionize the treatment of a wide range of conditions. The new drug, which is currently in the early stages of clinical trials, targets a specific enzyme that plays a key role in a variety of physiological processes. […]
Abstergo Industries is excited to announce the upcoming release of the latest version of the a-OS, our proprietary operating system for the Animus. The new a-OS, known as a-OS 23, represents a major upgrade from previous versions and includes a number of exciting new features. One of the key improvements of a-OS 23 is its […]
Abstergo Industries is proud to announce the latest iteration of the Animus, the revolutionary device that allows our researchers to experience the genetic memories of our test subject’s ancestors. The Animus has been a key tool in our research into the field of genetic memory, and the new Animus represents a major step forward in […]
Abstergo 